RU2018144785A3 - - Google Patents

Download PDF

Info

Publication number
RU2018144785A3
RU2018144785A3 RU2018144785A RU2018144785A RU2018144785A3 RU 2018144785 A3 RU2018144785 A3 RU 2018144785A3 RU 2018144785 A RU2018144785 A RU 2018144785A RU 2018144785 A RU2018144785 A RU 2018144785A RU 2018144785 A3 RU2018144785 A3 RU 2018144785A3
Authority
RU
Russia
Application number
RU2018144785A
Other languages
Russian (ru)
Other versions
RU2753525C2 (ru
RU2018144785A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2018144785A publication Critical patent/RU2018144785A/ru
Publication of RU2018144785A3 publication Critical patent/RU2018144785A3/ru
Application granted granted Critical
Publication of RU2753525C2 publication Critical patent/RU2753525C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
RU2018144785A 2016-05-19 2017-05-18 Применение соединения карбаминовой кислоты для профилактики или лечения фибромиалгии или функционального синдрома, ассоциированного с фибромиалгией RU2753525C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20160061392 2016-05-19
KR10-2016-0061392 2016-05-19
PCT/KR2017/005173 WO2017200318A1 (ko) 2016-05-19 2017-05-18 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도

Publications (3)

Publication Number Publication Date
RU2018144785A RU2018144785A (ru) 2020-06-19
RU2018144785A3 true RU2018144785A3 (cg-RX-API-DMAC7.html) 2020-08-11
RU2753525C2 RU2753525C2 (ru) 2021-08-17

Family

ID=60325216

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018144785A RU2753525C2 (ru) 2016-05-19 2017-05-18 Применение соединения карбаминовой кислоты для профилактики или лечения фибромиалгии или функционального синдрома, ассоциированного с фибромиалгией

Country Status (14)

Country Link
US (1) US10849882B2 (cg-RX-API-DMAC7.html)
EP (1) EP3459543B1 (cg-RX-API-DMAC7.html)
JP (1) JP7071287B2 (cg-RX-API-DMAC7.html)
KR (1) KR102489052B1 (cg-RX-API-DMAC7.html)
CN (1) CN109475529B (cg-RX-API-DMAC7.html)
AU (1) AU2017265839B2 (cg-RX-API-DMAC7.html)
BR (1) BR112018073553A2 (cg-RX-API-DMAC7.html)
CA (1) CA3024286A1 (cg-RX-API-DMAC7.html)
DK (1) DK3459543T3 (cg-RX-API-DMAC7.html)
ES (1) ES2935596T3 (cg-RX-API-DMAC7.html)
MX (1) MX394245B (cg-RX-API-DMAC7.html)
PL (1) PL3459543T3 (cg-RX-API-DMAC7.html)
RU (1) RU2753525C2 (cg-RX-API-DMAC7.html)
WO (1) WO2017200318A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX391363B (es) * 2016-12-14 2025-03-21 Sk Biopharmaceuticals Co Ltd Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el sindrome de temblor.
ES3027977T3 (en) * 2017-11-14 2025-06-17 Sk Biopharmaceuticals Co Ltd Use of a carbamate compound to prevent, alleviate or treat visceralgia or pain arising from visceral disease
EP3711760B1 (en) * 2017-11-14 2024-02-14 SK Biopharmaceuticals Co., Ltd. Use of carbamate compound for preventing or treating diseases associated with increase in late sodium current
MX2020004972A (es) 2017-11-14 2020-08-24 Sk Biopharmaceuticals Co Ltd Uso de compuesto de carbamato para prevenir, aliviar o tratar ataque de ausencia o epilepsia que muestra ataque de ausencia.
JP7369185B2 (ja) * 2018-10-19 2023-10-25 エスケー バイオファーマスティカルズ カンパニー リミテッド カルバメート化合物の糖尿病性末梢神経障害又は化学療法剤誘発性末梢神経障害の予防、緩和又は治療のための使用
JP7724776B2 (ja) * 2019-11-22 2025-08-18 エスケー バイオファーマスティカルズ カンパニー リミテッド カルバメート化合物を含む経口用医薬組成物及びその製造方法
IT202300007314A1 (it) 2023-04-14 2024-10-14 Soal Pharma Srl Integratore alimentare per il trattamento della fibromialgia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3415840A (en) * 1965-10-22 1968-12-10 American Home Prod Pyrazole-1-ethanol derivatives
DK1406606T3 (da) * 2001-07-16 2007-03-05 Ortho Mcneil Pharm Inc Carbamatforbindelser til forebyggelse eller behandling af neuropatisk smerte og smerte forbundet med klynge- og migrænehovedpine
US7598279B2 (en) * 2005-04-22 2009-10-06 Sk Holdings Co., Ltd. Neurotherapeutic azole compounds
PL2445890T3 (pl) 2009-06-22 2016-02-29 Sk Biopharmaceuticals Co Ltd Sposób wytwarzania estru (R)-1-arylo-2-tetrazoliloetylowego kwasu karbaminowego
US8404461B2 (en) * 2009-10-15 2013-03-26 SK Biopharmaceutical Co. Ltd. Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester
MX350745B (es) * 2009-11-06 2017-09-14 Sk Biopharmaceuticals Co Ltd * El uso de un compuesto de carbamoilo para el tratamiento del sindrome de fibromialgia.

Also Published As

Publication number Publication date
AU2017265839B2 (en) 2022-10-27
US10849882B2 (en) 2020-12-01
CN109475529B (zh) 2022-02-22
EP3459543A4 (en) 2020-01-15
WO2017200318A1 (ko) 2017-11-23
DK3459543T3 (da) 2023-02-13
EP3459543B1 (en) 2022-12-21
CN109475529A (zh) 2019-03-15
PL3459543T3 (pl) 2023-04-11
RU2753525C2 (ru) 2021-08-17
JP7071287B2 (ja) 2022-05-18
AU2017265839A1 (en) 2018-12-13
JP2019516707A (ja) 2019-06-20
EP3459543A1 (en) 2019-03-27
MX394245B (es) 2025-03-19
CA3024286A1 (en) 2017-11-23
KR102489052B1 (ko) 2023-01-16
ES2935596T3 (es) 2023-03-08
KR20170131242A (ko) 2017-11-29
US20190298694A1 (en) 2019-10-03
RU2018144785A (ru) 2020-06-19
BR112018073553A2 (pt) 2019-03-19
MX2018014080A (es) 2019-04-04

Similar Documents

Publication Publication Date Title
CH714036A1 (cg-RX-API-DMAC7.html)
BR122021017409A2 (cg-RX-API-DMAC7.html)
BR112019002665A2 (cg-RX-API-DMAC7.html)
BR112019009263A2 (cg-RX-API-DMAC7.html)
RU2018144785A3 (cg-RX-API-DMAC7.html)
BR112019009262A2 (cg-RX-API-DMAC7.html)
BR112019008087A2 (cg-RX-API-DMAC7.html)
BR202017015425U2 (cg-RX-API-DMAC7.html)
BR112019009373A2 (cg-RX-API-DMAC7.html)
BR202016021748U2 (cg-RX-API-DMAC7.html)
CN303536736S (cg-RX-API-DMAC7.html)
CN303537546S (cg-RX-API-DMAC7.html)
CN303536106S (cg-RX-API-DMAC7.html)
CN303536127S (cg-RX-API-DMAC7.html)
CN303536212S (cg-RX-API-DMAC7.html)
CN303536216S (cg-RX-API-DMAC7.html)
CN303536221S (cg-RX-API-DMAC7.html)
CN303536278S (cg-RX-API-DMAC7.html)
CN303536284S (cg-RX-API-DMAC7.html)
CN303536357S (cg-RX-API-DMAC7.html)
CN303536361S (cg-RX-API-DMAC7.html)
CN303536428S (cg-RX-API-DMAC7.html)
CN303536593S (cg-RX-API-DMAC7.html)
CN303536597S (cg-RX-API-DMAC7.html)
CN303545093S (cg-RX-API-DMAC7.html)